Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,266,934 | 2,266,934 | 0 | $53.11M | $55.54M | 61.51% | +$2.43M |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 20,162,332 | 0 | $29.24M | $27.82M | 30.81% | -$1.41M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $9.21M | $6.94M | 7.68% | -$2.28M |